230 related articles for article (PubMed ID: 24765590)
1. Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.
Whigham LD; Butz DE; Dashti H; Tonelli M; Johnson LK; Cook ME; Porter WP; Eghbalnia HR; Markley JL; Lindheim SR; Schoeller DA; Abbott DH; Assadi-Porter FM
Curr Metabolomics; 2014; 2(4):269-278. PubMed ID: 24765590
[TBL] [Abstract][Full Text] [Related]
2. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
3. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomics of Indian women with polycystic ovary syndrome using
RoyChoudhury S; Mishra BP; Khan T; Chattopadhayay R; Lodh I; Datta Ray C; Bose G; Sarkar HS; Srivastava S; Joshi MV; Chakravarty B; Chaudhury K
Mol Biosyst; 2016 Oct; 12(11):3407-3416. PubMed ID: 27714060
[TBL] [Abstract][Full Text] [Related]
5. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
8. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
9. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
11. Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.
Wang Y; Zhou W; Wu C; Zhang Y; Lin T; Sun Y; Liu W; Tao T
Reprod Biol Endocrinol; 2018 Mar; 16(1):31. PubMed ID: 29587769
[TBL] [Abstract][Full Text] [Related]
12. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.
Cenk Sayin N; Gücer F; Balkanli-Kaplan P; Ali Yüce M; Yardim T
Gynecol Endocrinol; 2003 Oct; 17(5):387-96. PubMed ID: 14710586
[TBL] [Abstract][Full Text] [Related]
16. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
[TBL] [Abstract][Full Text] [Related]
17. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
[TBL] [Abstract][Full Text] [Related]
18. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
19. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
Chapman IM; Wittert GA; Norman RJ
Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS).
Kinoshita T; Kato J
Horm Res; 1990; 33 Suppl 2():18-20. PubMed ID: 2095356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
